
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
299.050
Open
296.800
VWAP
291.54
Vol
4.66M
Mkt Cap
178.45B
Low
284.600
Amount
1.36B
EV/EBITDA(TTM)
16.29
Total Shares
626.38M
EV
192.94B
EV/OCF(TTM)
18.54
P/S(TTM)
2.95
Accenture plc is a global professional services company. The Company is engaged in providing a range of services and solutions across strategy and consulting, technology, operations, Industry X and Accenture Song. Its services include application ser...Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
17.28B
+4.94%
3.314
+5.87%
17.05B
+3.93%
2.982
+6.89%
18.46B
+4.36%
3.736
+4.05%
Estimates Revision
The market is revisingDownwardthe revenue expectations for Accenture plc (ACN) for FY2025, with the revenue forecasts being adjusted by -0.11%over the past three months. During the same period, the stock price has changed by-18.86%.
Revenue Estimates for FY2025
Revise Downward

-0.11%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-0.07%
In Past 3 Month
Stock Price
Go Down

-18.86%
In Past 3 Month
20 Analyst Rating

30.72% Upside
Wall Street analysts forecast ACN stock price to riseover the next 12 months. According to Wall Street analysts, the average 1-year price target for ACN is 372.63USD with a low forecast of290.00USD and a high forecast of425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Buy
5 Hold
0 Sell
Strong Buy

30.72% Upside
Current: 285.060

Low
290.00
Averages
372.63
High
425.00
Barclays
Ramsey El-Assal
Buy
Maintains
$415 → $390
2025-03-24
Reason
Barclays reiterated an Overweight rating and $415 price target on Accenture after the company reported a slight Q2 top/bottom-line beat and raised the midpoint of its FY25 guidance, despite a volatile political and economic environment. The firm said the stock has overcorrected on DOGE fears, and that it would be a buyer on the weakness. Barclays added that while it views a portion off Accenture Federal Services work as at-risk, it has yet to see large-scale cancellations, and that the downward move in recent weeks is overdone.
Baird
David Koning
Buy
Maintains
$390 → $372
2025-03-21
Reason
Baird upgraded Accenture to Outperform from Neutral with an unchanged price target of $390. The firm says the stock has been weak the past few years on "sluggish" IT demand and more recently Department of Government Efficiency fears as U.S. federal spend was 8% of Accenture's fiscal 2024 revenue. The analyst expects the company's fiscal Q2 to beat estimates "mildly" and views its Managed Services demand to be strong, which is 50% of revenue. Accenture can return to favor given its "strong moat," free cash flow and accelerating growth, and can ultimately benefit from generative artificial intelligence demand, the analyst tells investors in a research note.
Guggenheim
Jonathan Lee
Strong Buy
Maintains
$400 → $395
2025-03-21
Reason
Guggenheim lowered the firm's price target on Accenture to $395 from $400 and keeps a Buy rating on the shares. Management's protection of the high-end of its FY25 revenue growth outlook despite elevated economic and geopolitical uncertainty, is likely to draw skepticism, the analyst tells investors in a research note. Guggenheim remains constructive on Accenture shares over the medium-term as the firm continues to see the company benefiting from delivering on clients' cost optimization initiatives and aiding in enterprises' transformational agendas.
UBS
Kevin Mcveigh
Strong Buy
Maintains
$455 → $387
2025-03-21
Reason
RBC Capital
Daniel Perlin
Buy
Maintains
$399 → $392
2025-03-21
Reason
RBC Capital lowered the firm's price target on Accenture to $392 from $399 and keeps an Outperform rating on the shares. The company delivered solid Q2 numbers, but the shares are reacting negatively to management commentary emphasizing a lack of visibility from DOGE-driven contract reviews of federal work as well as a broader concern of uncertainty from clients, which may stunt spending decisions, particularly on discretionary work, the analyst tells investors in a research note. Demand environment has not bottomed and will continue to weigh on Accenture's growth outlook, RBC added.
Piper Sandler
Arvind Ramnani
Buy
Maintains
$396 → $364
2025-03-20
Reason
Mizuho
Dan Dolev
Buy
Maintains
$428 → $398
2025-03-19
Reason
Mizuho lowered the firm's price target on Accenture to $398 from $428 and keeps an Outperform rating on the shares ahead of the Q2 results on Thursday. The firm wonders whether Q2 will be as "impressive" as Q1 amid fresh macro uncertainty, and while the firm remains upbeat about Accenture being a best-in-class operator, potential risks heading into the earnings include another delay in the anticipated positive inflection in Mizuho's proprietary operating expense growth analysis for the S&P 500 constituents, a small downtick in Mizuho's IT Jobs tracker, and accelerating news flow regarding the potential adverse impact of DOGE on government IT budgets, the analyst tells investors in a research note.
BMO Capital
Keith Bachman
Hold
Maintains
$425 → $370
2025-03-18
Reason
BMO Capital lowered the firm's price target on Accenture to $370 from $425 and keeps a Market Perform rating on the shares ahead of its Q2 results this week. The firm anticipates upside to consensus revenue estimates for the quarter but does not expect a raise in previously provided full-year guidance given the incremental uncertainty in the economy and headwinds in the federal government services business, the analyst tells investors in a research note. Valuation is more appealing given the stock's pullback, but estimates will likely remain range bound over the medium term, BMO added.
Baird
David Koning
Hold
to
Buy
Upgrades
$390
2025-03-17
Reason
Baird upgraded Accenture to Outperform from Neutral with an unchanged price target of $390. The firm says the stock has been weak the past few years on "sluggish" IT demand and more recently Department of Government Efficiency fears as U.S. federal spend was 8% of Accenture's fiscal 2024 revenue. The analyst expects the company's fiscal Q2 to beat estimates "mildly" and views its Managed Services demand to be strong, which is 50% of revenue. Accenture can return to favor given its "strong moat," free cash flow and accelerating growth, and can ultimately benefit from generative artificial intelligence demand, the analyst tells investors in a research note.
Morgan Stanley
James Faucette
Hold
Maintains
$380 → $372
2025-03-17
Reason
Morgan Stanley lowered the firm's price target on Accenture to $372 from $380 and keeps an Equal Weight rating on the shares ahead of the company's fiscal Q2 report scheduled for Thursday, March 20, before market open. The firm expects management to raise the bottom-end of the FY25 growth outlook by 100 basis point to 5-7% year-over-year in constant currency while maintaining margin expansion targets, but notes that investor sentiment skews negative and thinks its trimmed estimates are "generally consistent with buyside expectations."
Valuation Metrics
The current forward P/E ratio for Accenture PLC(ACN.N) is 21.93, compared to its 5-year average forward P/E of 27.55. For a more detailed relative valuation and DCF analysis to assess Accenture PLC 's fair value, click here.
Forward PE

Undervalued
5Y Average PE
27.55
Current PE
21.93
Overvalued PE
30.90
Undervalued PE
24.20
Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
16.25
Current EV/EBITDA
14.16
Overvalued EV/EBITDA
17.94
Undervalued EV/EBITDA
14.56
Forward PS

Undervalued
5Y Average PS
3.10
Current PS
2.68
Overvalued PS
3.46
Undervalued PS
2.75
Financials
Annual
Quarterly
FY2025Q2
YoY :
+5.44%
16.66B
Total Revenue
FY2025Q2
YoY :
+3.83%
2.24B
Operating Profit
FY2025Q2
YoY :
+6.63%
1.82B
Net Income after Tax
FY2025Q2
YoY :
+7.22%
2.82
EPS - Diluted
FY2025Q2
YoY :
+34.72%
2.68B
Free Cash Flow
FY2025Q2
YoY :
-3.30%
29.86
Gross Profit Margin - %
FY2025Q2
YoY :
+6.46%
14.50
FCF Margin - %
FY2025Q2
YoY :
+1.11%
10.94
Net Margin - %
FY2025Q2
YoY :
-8.71%
24.52
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
5.1M
USD
4
3-6
Months
6.8M
USD
10
6-9
Months
14.4M
USD
9
0-12
Months
12.3M
USD
8
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
634.0K
Volume
21
6-9
Months
0.0
Volume
0
0-12
Months
1.0M
Volume
28
Bought
0-3
0
0.0
Volume
Months
3-6
17
763.0K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
62
6.4M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.0K
USD
1
3-6
Months
8.0K
USD
1
6-9
Months
24.0K
USD
3
0-12
Months
91.0K
USD
3
Bought
0-3
3
91.0K
USD
Months
3-6
1
8.0K
USD
Months
6-9
3
91.0K
USD
Months
0-12
1
8.0K
USD
Months
ACN News & Events
Events Timeline
2025-03-31 (ET)
2025-03-31
05:30:47
Siemens, Accenture form Accenture Siemens Business Group

2025-03-25 (ET)
2025-03-25
17:23:13
Accenture awarded $336.83M Air Force contract

2025-03-20 (ET)
2025-03-20
10:00:44
Accenture falls -9.0%

2025-03-20
06:41:39
Accenture narrows FY25 EPS view to $12.55-$12.79 from $12.43-$12.79

2025-03-20
06:39:39
Accenture reports Q2 EPS $2.82, consensus $2.81

2025-03-19 (ET)
2025-03-19
20:25:00
Notable companies reporting before tomorrow's open

2025-03-19
14:12:29
Notable companies reporting before tomorrow's open

2025-03-18 (ET)
2025-03-18
16:18:10
Accenture expands AI refinery, launches new industry agent solutions

2025-03-18
15:14:37
Nvidia announces open Llama Nemotron family of models

2025-03-13 (ET)
2025-03-13
08:19:07
Accenture makes strategic investment in OPAQUE to advance confidential AI

2025-03-12 (ET)
2025-03-12
08:10:03
Accenture and CrowdStrike team on real-time threat visibility and prevention

2025-03-04 (ET)
2025-03-04
09:37:48
Accenture Ventures invests in Aaru

News
7.0
04-02SeekingAlphaTop U.S. consulting firms are said to offer cost cuts amid federal scrutiny
3.0
04-01NASDAQ.COMGuru Fundamental Report for ACN - Warren Buffett
2.0
04-01NASDAQ.COMAccenture is Oversold
7.5
03-31BenzingaSiemens, Accenture Deepen Alliance With New Business Group Targeting AI-Driven Engineering
7.5
03-31NewsfilterNew Accenture Siemens Business Group to Reinvent Engineering and Manufacturing for Clients
4.5
03-26SeekingAlphaCognizant highlights strategy, targets at investor event: analysts weigh in
6.0
03-25Business InsiderAccenture awarded $336.83M Air Force contract
6.5
03-25SeekingAlphaSA Asks: What's next for consulting firms like Accenture, Booz Allen?
6.5
03-25Business InsiderAnalysts’ Opinions Are Mixed on These Technology Stocks: Accenture (ACN) and Micron (MU)
4.0
03-24Yahoo FinanceIs Accenture Stock Going to $364? 1 Wall Street Analyst Thinks So.
2.0
03-24BenzingaAccenture Shares Rise Over 2.5% After Key Signal
3.0
03-24Yahoo FinanceAccenture PLC: An Exploration into Its Intrinsic Value
6.5
03-24TipRanksBarclays Flags 4 Stocks at Risk amid Musk-Led DOGE Spending Cuts
3.5
03-23Yahoo FinanceAccenture (ACN) Introduces AI Agent Builder to Scale Enterprise AI
6.0
03-23Business InsiderAccenture price target lowered to $373 from $431 at BofA
3.0
03-23NASDAQ.COMGuru Fundamental Report for ACN - Warren Buffett
6.0
03-23Business InsiderAccenture (ACN) Gets a Buy from Bank of America Securities
4.0
03-22Yahoo FinanceAccenture price target lowered to $365 from $394 at TD Cowen
4.5
03-22SeekingAlphaTrending stocks this week as markets gingerly turn green
8.0
03-22BenzingaBig Short Investor Danny Moses Warns Of Economic Risks From Elon Musk's DOGE-Induced Federal Job Cuts
People Also Watch

AMSC
American Superconductor Corp
15.800
USD
-5.22%

PSFE
Paysafe Ltd
14.160
USD
-5.35%

RCKT
Rocket Pharmaceuticals Inc
5.120
USD
-7.91%

ACMR
ACM Research Inc
20.300
USD
-9.17%

CCEC
Capital Clean Energy Carriers Corp
18.230
USD
-7.93%

PEBO
Peoples Bancorp Inc
27.280
USD
-0.98%

KRO
Kronos Worldwide Inc
6.690
USD
-4.15%

PENG
Penguin Solutions Inc
15.190
USD
-6.18%

STAA
STAAR Surgical Co
15.920
USD
-8.51%

PLSE
Pulse Biosciences Inc
15.080
USD
+3.79%
FAQ

What is Accenture PLC (ACN) stock price today?
The current price of ACN is 285.06 USD — it hasdecreased-5.44 % in the last trading day.

What is Accenture PLC (ACN)'s business?

What is the price predicton of ACN Stock?

What is Accenture PLC (ACN)'s revenue for the last quarter?

What is Accenture PLC (ACN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Accenture PLC (ACN)'s fundamentals?

How many employees does Accenture PLC (ACN). have?
